FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046476894> ?p ?o ?g. }

• W2046476894 endingPage "38" @default.
• W2046476894 startingPage "29" @default.
• W2046476894 abstract "Ovarian and uterine carcinosarcoma (CS) are characterized by their aggressive clinical behavior and poor prognosis. We evaluated the efficacy of trastuzumab-emtansine (T-DM1), against primary HER2 positive and HER2 negative CS cell lines in vitro and in vivo. Eight primary CS cell lines were evaluated for HER2 amplification and protein expression by fluorescence in situ hybridization, immunohistochemistry, flow cytometry and qRT-PCR. Sensitivity to T-DM1-induced antibody-dependent-cell-mediated-cytotoxicity (ADCC) was evaluated in 4-h-chromium-release-assays. T-DM1 cytostatic and apoptotic activities were evaluated using flow cytometry based proliferation assays. In vivo activity of T-DM1 was also evaluated. HER2 protein overexpression and gene amplification were detected in 25 % (2/8) of the primary CS cell lines. T-DM1 and T were similarly effective in inducing strong ADCC against CS overexpressing HER2 at 3+ levels. In contrast, T-DM1 was dramatically more effective than T in inhibiting cell proliferation (P < 0.0001) and in inducing G2/M phase cell cycle arrest in the HER2 expressing cell lines (shift of G2/M: mean ± SEM from 14.87 ± 1.23 to 66.57 ± 4.56 %, P < 0.0001). Importantly, T-DM1 was highly active at reducing tumor formation in vivo in CS xenografts overexpressing HER2 (P = 0.0001 and P < 0.0001 compared to T and vehicle respectively) with a significantly longer survival when compared to T and vehicle mice (P = 0.008 and P = 0.0001 respectively). T-DM1 may represent a novel treatment option for the subset of HER2 positive CS patients with disease refractory to chemotherapy." @default.
• W2046476894 created "2016-06-24" @default.
• W2046476894 creator A5008166734 @default.
• W2046476894 creator A5010339370 @default.
• W2046476894 creator A5024732018 @default.
• W2046476894 creator A5026827320 @default.
• W2046476894 creator A5027337412 @default.
• W2046476894 creator A5029807655 @default.
• W2046476894 creator A5035381883 @default.
• W2046476894 creator A5037526893 @default.
• W2046476894 creator A5041717556 @default.
• W2046476894 creator A5041993659 @default.
• W2046476894 creator A5045925318 @default.
• W2046476894 creator A5046857977 @default.
• W2046476894 creator A5054033479 @default.
• W2046476894 creator A5061703014 @default.
• W2046476894 creator A5069575202 @default.
• W2046476894 creator A5083529085 @default.
• W2046476894 date "2014-11-15" @default.
• W2046476894 modified "2023-10-02" @default.
• W2046476894 title "T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2" @default.
• W2046476894 cites W1607066470 @default.
• W2046476894 cites W1968590850 @default.
• W2046476894 cites W1979494894 @default.
• W2046476894 cites W1983345423 @default.
• W2046476894 cites W1984007340 @default.
• W2046476894 cites W1987362747 @default.
• W2046476894 cites W1988373577 @default.
• W2046476894 cites W1997056190 @default.
• W2046476894 cites W2005202092 @default.
• W2046476894 cites W2005553722 @default.
• W2046476894 cites W2007738151 @default.
• W2046476894 cites W2009881557 @default.
• W2046476894 cites W2010158032 @default.
• W2046476894 cites W2019293853 @default.
• W2046476894 cites W2019658166 @default.
• W2046476894 cites W2020895944 @default.
• W2046476894 cites W2031947447 @default.
• W2046476894 cites W2039241242 @default.
• W2046476894 cites W2046393549 @default.
• W2046476894 cites W2046551180 @default.
• W2046476894 cites W2047518202 @default.
• W2046476894 cites W2055922116 @default.
• W2046476894 cites W2072176789 @default.
• W2046476894 cites W2073547414 @default.
• W2046476894 cites W2076953008 @default.
• W2046476894 cites W2080588809 @default.
• W2046476894 cites W2119870604 @default.
• W2046476894 cites W2130900820 @default.
• W2046476894 cites W2139690050 @default.
• W2046476894 cites W2142851253 @default.
• W2046476894 cites W2159459001 @default.
• W2046476894 cites W2159967578 @default.
• W2046476894 cites W2161574596 @default.
• W2046476894 doi "https://doi.org/10.1007/s10585-014-9688-8" @default.
• W2046476894 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4310789" @default.
• W2046476894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25398397" @default.
• W2046476894 hasPublicationYear "2014" @default.
• W2046476894 type Work @default.
• W2046476894 sameAs 2046476894 @default.
• W2046476894 citedByCount "49" @default.
• W2046476894 countsByYear W20464768942015 @default.
• W2046476894 countsByYear W20464768942016 @default.
• W2046476894 countsByYear W20464768942017 @default.
• W2046476894 countsByYear W20464768942018 @default.
• W2046476894 countsByYear W20464768942019 @default.
• W2046476894 countsByYear W20464768942020 @default.
• W2046476894 countsByYear W20464768942021 @default.
• W2046476894 countsByYear W20464768942022 @default.
• W2046476894 countsByYear W20464768942023 @default.
• W2046476894 crossrefType "journal-article" @default.
• W2046476894 hasAuthorship W2046476894A5008166734 @default.
• W2046476894 hasAuthorship W2046476894A5010339370 @default.
• W2046476894 hasAuthorship W2046476894A5024732018 @default.
• W2046476894 hasAuthorship W2046476894A5026827320 @default.
• W2046476894 hasAuthorship W2046476894A5027337412 @default.
• W2046476894 hasAuthorship W2046476894A5029807655 @default.
• W2046476894 hasAuthorship W2046476894A5035381883 @default.
• W2046476894 hasAuthorship W2046476894A5037526893 @default.
• W2046476894 hasAuthorship W2046476894A5041717556 @default.
• W2046476894 hasAuthorship W2046476894A5041993659 @default.
• W2046476894 hasAuthorship W2046476894A5045925318 @default.
• W2046476894 hasAuthorship W2046476894A5046857977 @default.
• W2046476894 hasAuthorship W2046476894A5054033479 @default.
• W2046476894 hasAuthorship W2046476894A5061703014 @default.
• W2046476894 hasAuthorship W2046476894A5069575202 @default.
• W2046476894 hasAuthorship W2046476894A5083529085 @default.
• W2046476894 hasBestOaLocation W20464768942 @default.
• W2046476894 hasConcept C109316439 @default.
• W2046476894 hasConcept C121608353 @default.
• W2046476894 hasConcept C126322002 @default.
• W2046476894 hasConcept C150903083 @default.
• W2046476894 hasConcept C153911025 @default.
• W2046476894 hasConcept C159654299 @default.
• W2046476894 hasConcept C185592680 @default.
• W2046476894 hasConcept C190283241 @default.
• W2046476894 hasConcept C202751555 @default.
• W2046476894 hasConcept C203014093 @default.

• next